Treatment outcome of switching from ranibizumab to aflibercept in patients with central retinal vein occlusion

被引:0
作者
Konidaris, V.
Gorgoli, K.
Burgula, S.
Deane, J.
Banerjee, S.
Empeslidis, T.
机构
关键词
D O I
10.1111/j.1755-3768.2016.0316
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
引用
收藏
页数:2
相关论文
共 50 条
[21]   Real-World Results of Switching Treatment from Ranibizumab to Aflibercept in Macular Oedema Secondary to Branch Retinal Vein Occlusion [J].
Konidaris, Vasileios E. ;
Tsaousis, Konstantinos T. ;
Anzidei, Rossella ;
de la Mata, Guillermo ;
Brent, Alexander J. .
OPHTHALMOLOGY AND THERAPY, 2018, 7 (02) :387-395
[22]   Early treatment with ranibizumab in severe central retinal vein occlusion [J].
Rostaqui, Olga ;
Glacet-Bernard, Agnes ;
Massamba, Nathalie ;
Zerbib, Jennyfer ;
Coscas, Florence ;
Coscas, Gabriel ;
Souied, Eric .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
[23]   Ranibizumab treatment of retinal vein occlusion [J].
Johnson, Robert N. .
EXPERT REVIEW OF OPHTHALMOLOGY, 2012, 7 (06) :509-515
[24]   Comparing Cytokine Kinetics between Ranibizumab and Aflibercept in Central Retinal Vein Occlusion with Macular Edema [J].
Kotake, Osamu ;
Noma, Hidetaka ;
Yasuda, Kanako ;
Motohashi, Ryosuke ;
Goto, Hiroshi ;
Shimura, Masahiko .
OPHTHALMIC RESEARCH, 2019, 61 (04) :210-217
[25]   Aflibercept versus bevacizumab and/or ranibizumab for recurrent macular edema secondary to central retinal vein occlusion [J].
Dedania, Vaidehi ;
Ozgonul, Cem ;
Besirli, Cagri G. .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
[26]   Aflibercept Versus Bevacizumab and/or Ranibizumab for Recurrent Macular Edema Secondary to Central Retinal Vein Occlusion [J].
Ozgonul, Cem ;
Dedania, Vaidehi S. ;
Besirli, Cagri G. .
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2018, 34 (04) :340-345
[27]   Retinal vascular oximetry during ranibizumab treatment of central retinal vein occlusion [J].
Traustason, Sindri ;
la Cour, Morten ;
Larsen, Michael .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2014, 98 (09) :1208-1211
[28]   Intravitreal aflibercept use in the treatment of macular edema from central retinal vein occlusion [J].
Carle, Michelle V. ;
Chu, Thomas G. ;
Tabandeh, Homayoun ;
Boyer, David S. .
EXPERT REVIEW OF OPHTHALMOLOGY, 2013, 8 (03) :227-235
[29]   EFFECTS OF SWITCHING TO AFLIBERCEPT IN THE TREATMENT OF MACULAR OEDEMA SECONDARY TO RETINAL VEIN OCCLUSION [J].
Spooner, Kimberly ;
Hong, Thomas ;
Fraser-Bell, Samantha ;
Chang, Andrew .
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2018, 46 :124-124
[30]   RESPONSE TO AFLIBERCEPT AS SECONDARY THERAPY IN PATIENTS WITH PERSISTENT RETINAL EDEMA DUE TO CENTRAL RETINAL VEIN OCCLUSION INITIALLY TREATED WITH BEVACIZUMAB OR RANIBIZUMAB [J].
Eadie, James A. ;
Ip, Michael S. ;
Kulkarni, Amol D. .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2014, 34 (12) :2439-2443